Who are Harness Therapeutics Ltd's investors?

Harness Therapeutics Ltd's investors include Epidarex Capital, Ono Venture Investment, Inc., Dementia Discovery Fund, SV Health Investors.

Harness Therapeutics Ltd

Founded 2023 · 34 employees on LinkedIn · 4 known investors

Find your way into Harness Therapeutics Ltd

Paths you didn't know you had: your email and LinkedIn already hold routes to the Harness Therapeutics Ltd team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Harness Therapeutics develops disease-modifying precision therapies for hard-to-treat neurodegenerative diseases through controlled modulation of CNS targets. Its pipeline targets conditions including Huntington's disease, Parkinson's disease, Alzheimer's disease, and ALS, using expertise in RNA biology and targeted protein modulation.

Biotech Healthtech

Founders & leadership

Jan ThirkettleCEO Director

Investors · 4

Epidarex Capital✓ confirmed by Harness Therapeutics LtdBethesda · $2.5M – $6.3M

How we know: Epidarex Capital's portfolio page · the company's own site · open dataset · 5k.vc investor directory · Not right? Tell us

Ono Venture Investment, Inc.✓ confirmed by Harness Therapeutics LtdSouth San Francisco

How we know: the company's own site · Ono Venture Investment, Inc.'s portfolio page · Not right? Tell us

Dementia Discovery Fund✓ confirmed by Harness Therapeutics LtdLondon

How we know: the company's own site · Not right? Tell us

SV Health Investors✓ confirmed by Harness Therapeutics LtdLondon · $1M – $20M

How we know: the company's own site · open dataset · 5k.vc investor directory · Not right? Tell us

Related companies · 2

BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.

AbcamSupplier of protein research tools to life scientists. Publicly listed on the LSE following an IPO.

Companies working in the same space as Harness Therapeutics Ltd.

Frequently asked questions

What does Harness Therapeutics Ltd do?: Harness Therapeutics develops disease-modifying precision therapies for hard-to-treat neurodegenerative diseases through controlled modulation of CNS targets. Its pipeline targets conditions including Huntington's disease, Parkinson's disease, Alzheimer's disease, and ALS, using expertise in RNA biology and targeted protein modulation.
Who are Harness Therapeutics Ltd's investors?: Harness Therapeutics Ltd's investors include Epidarex Capital, Ono Venture Investment, Inc., Dementia Discovery Fund, SV Health Investors.